These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19067257)

  • 1. The effect of Saccharomyces boulardii on reducing irinotecan-induced intestinal mucositis and diarrhea.
    Sezer A; Usta U; Cicin I
    Med Oncol; 2009; 26(3):350-7. PubMed ID: 19067257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis.
    Logan RM; Gibson RJ; Bowen JM; Stringer AM; Sonis ST; Keefe DM
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):33-41. PubMed ID: 17703303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile.
    Stringer AM; Gibson RJ; Bowen JM; Logan RM; Ashton K; Yeoh AS; Al-Dasooqi N; Keefe DM
    Int J Exp Pathol; 2009 Oct; 90(5):489-99. PubMed ID: 19765103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation.
    Lima-Júnior RC; Figueiredo AA; Freitas HC; Melo ML; Wong DV; Leite CA; Medeiros RP; Marques-Neto RD; Vale ML; Brito GA; Oriá RB; Souza MH; Cunha FQ; Ribeiro RA
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):931-42. PubMed ID: 22101361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Velafermin improves gastrointestinal mucositis following irinotecan treatment in tumor-bearing DA rats.
    Gibson RJ; Stringer AM; Bowen JM; Logan RM; Yeoh AS; Burns J; Alvarez E; Keefe DM
    Cancer Biol Ther; 2007 Apr; 6(4):541-7. PubMed ID: 17457046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum-derived bovine immunoglobulin/protein isolate in the alleviation of chemotherapy-induced mucositis.
    Bateman E; Weaver E; Klein G; Wignall A; Wozniak B; Plews E; Mayo B; White I; Keefe D
    Support Care Cancer; 2016 Jan; 24(1):377-385. PubMed ID: 26081596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a single-dose irinotecan model of gastrointestinal mucositis.
    Gibson RJ; Bowen JM; Alvarez E; Finnie J; Keefe DM
    Chemotherapy; 2007; 53(5):360-9. PubMed ID: 17713326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified irinotecan hydrochloride (CPT-11) administration schedule improves induction of delayed-onset diarrhea in rats.
    Kurita A; Kado S; Kaneda N; Onoue M; Hashimoto S; Yokokura T
    Cancer Chemother Pharmacol; 2000; 46(3):211-20. PubMed ID: 11021738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palifermin reduces diarrhea and increases survival following irinotecan treatment in tumor-bearing DA rats.
    Gibson RJ; Bowen JM; Keefe DM
    Int J Cancer; 2005 Sep; 116(3):464-70. PubMed ID: 15800945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti rat.
    Al-Dasooqi N; Gibson RJ; Bowen JM; Logan RM; Stringer AM; Keefe DM
    Exp Biol Med (Maywood); 2010 Oct; 235(10):1244-56. PubMed ID: 20682600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saccharomyces cerevisiae UFMG A-905 treatment reduces intestinal damage in a murine model of irinotecan-induced mucositis.
    Bastos RW; Pedroso SH; Vieira AT; Moreira LM; França CS; Cartelle CT; Arantes RM; Generoso SV; Cardoso VN; Neves MJ; Nicoli JR; Martins FS
    Benef Microbes; 2016 Sep; 7(4):549-57. PubMed ID: 27133563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An experimental study: the effect of S. boulardii on abemaciclibinduced diarrhea.
    Cakcak İE; Aytın YE; Sayın S; Küçükarda A; Gökyer A; Gökmen İ; Özcan E; Korkmaz S; Taştekin E; Çiçin İ
    Turk J Med Sci; 2023 Feb; 53(1):51-57. PubMed ID: 36945921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amitriptyline prevents CPT-11-induced early-onset diarrhea and colonic apoptosis without reducing overall gastrointestinal damage in a rat model of mucositis.
    Fakiha K; Coller JK; Logan RM; Gibson RJ; Bowen JM
    Support Care Cancer; 2019 Jun; 27(6):2313-2320. PubMed ID: 30350190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell adhesion molecules are altered during irinotecan-induced mucositis: a qualitative histopathological study.
    Al-Dasooqi N; Bowen J; Bennett C; Finnie J; Keefe D; Gibson R
    Support Care Cancer; 2017 Feb; 25(2):391-398. PubMed ID: 27650103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide.
    Yang XX; Hu ZP; Chan SY; Duan W; Ho PC; Boelsterli UA; Ng KY; Chan E; Bian JS; Chen YZ; Huang M; Zhou SF
    Curr Drug Metab; 2006 May; 7(4):431-55. PubMed ID: 16724931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Adaptor Protein Myd88 Is a Key Signaling Molecule in the Pathogenesis of Irinotecan-Induced Intestinal Mucositis.
    Wong DV; Lima-Júnior RC; Carvalho CB; Borges VF; Wanderley CW; Bem AX; Leite CA; Teixeira MA; Batista GL; Silva RL; Cunha TM; Brito GA; Almeida PR; Cunha FQ; Ribeiro RA
    PLoS One; 2015; 10(10):e0139985. PubMed ID: 26440613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with Saccharomyces boulardii reduces the inflammation and dysfunction of the gastrointestinal tract in 5-fluorouracil-induced intestinal mucositis in mice.
    Justino PF; Melo LF; Nogueira AF; Costa JV; Silva LM; Santos CM; Mendes WO; Costa MR; Franco AX; Lima AA; Ribeiro RA; Souza MH; Soares PM
    Br J Nutr; 2014 May; 111(9):1611-21. PubMed ID: 24503021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives.
    Ribeiro RA; Wanderley CW; Wong DV; Mota JM; Leite CA; Souza MH; Cunha FQ; Lima-Júnior RC
    Cancer Chemother Pharmacol; 2016 Nov; 78(5):881-893. PubMed ID: 27590709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of intestinal UDP-glucuronosyltransferases in modulating 7-ethyl-10-hydroxy-camptothecin (SN-38)-induced gastrointestinal toxicity in rats.
    Tallman MN; Miles KK; Kessler FK; Nielsen JN; Tian X; Ritter JK; Smith PC
    J Pharmacol Exp Ther; 2007 Jan; 320(1):29-37. PubMed ID: 17003228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irinotecan-induced mucositis is associated with changes in intestinal mucins.
    Stringer AM; Gibson RJ; Logan RM; Bowen JM; Yeoh AS; Laurence J; Keefe DM
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):123-32. PubMed ID: 18998135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.